CD39+ regulatory T cells attenuate allergic airway inflammation

Clinical and Experimental Allergy

Volumn 45, Issue 6, 2015, Pages 1126-1137

  Li, P ^a   Gao, Y ^a   Cao, J ^a   Wang, W ^a   Chen, Y ^a   Zhang, G ^a   Robson, S C ^b   Wu, Y ^b   Yang, J ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenosine; Allergic asthma; ATP; CD39; Regulatory T cells

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR ANTAGONIST; APYRASE; BETA,GAMMA DIBROMOMETHYLENE 6 N,N DIETHYLADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; ADENOSINE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN;

AIRWAY RESISTANCE; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD39+ REGULATORY T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GOBLET CELL; IN VITRO STUDY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCANNING ELECTRON MICROSCOPY; TH17 CELL; TH2 CELL; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; LUNG; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; RESPIRATORY TRACT ALLERGY; T LYMPHOCYTE SUBPOPULATION;

ADENOSINE; ANIMALS; ANTIGENS, CD; APYRASE; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; LUNG; LYMPHOCYTE COUNT; MICE; MICE, KNOCKOUT; RESPIRATORY HYPERSENSITIVITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84929318038     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12521     Document Type: Article

References (38)

1. Hamid Q, Tulic M. Immunobiology of asthma. Annu Rev Physiol 2009; 71:489-507.
2. Robinson DS. Regulatory T cells and asthma. Clin Exp Allergy 2009; 39:1314-23.
3. Nakagome K, Imamura M, Okada H et al. Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation. J Immunol 2011; 186:5975-82.
4. Wang LH, Lin YH, Yang J, Guo W. Insufficient increment of CD4 + CD25 + regulatory T cells after stimulation in vitro with allergen in allergic asthma. Int Arch Allergy Immunol 2009; 148:199-210.
5. Kearley J, Robinson DS, Lloyd CM. CD4 + CD25 + regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 2008; 122(617-24):e6.
6. Thorburn AN, Hansbro PM. Harnessing regulatory T cells to suppress asthma: from potential to therapy. Am J Respir Cell Mol Biol 2010; 43:511-9.
7. Deaglio S, Dwyer KM, Gao W et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204:1257-65.
8. Salcido-Ochoa F, Tsang J, Tam P et al. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? Transplant Rev (Orlando) 2010; 24:52-66.
9. Borsellino G, Kleinewietfeld M, Di Mitri D et al. Expression of ectonucleotidase CD39 by Foxp3 + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110:1225-32.
10. Dwyer KM, Deaglio S, Gao W et al. CD39 and control of cellular immune responses. Purinergic Signal 2007; 3:171-80.
11. Zhou Q, Yan J, Putheti P et al. Isolated CD39 expression on CD4 + T cells denotes both regulatory and memory populations. Am J Transplant 2009; 9:2303-11.
12. Mandapathil M, Lang S, Gorelik E, Whiteside TL. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 2009; 346:55-63.
13. Fletcher JM, Lonergan R, Costelloe L et al. CD39 + Foxp3 + regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 2009; 183:7602-10.
14. Muller T, Robaye B, Vieira RP et al. The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy 2010; 65:1545-53.
15. Idzko M, Hammad H, van Nimwegen M et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007; 13:913-9.
16. Muller T, Vieira RP, Grimm M et al. A potential role for P2X7R in allergic airway inflammation in mice and humans. Am J Respir Cell Mol Biol 2011; 44:456-64.
17. Manthei DM, Jackson DJ, Evans MD et al. Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function. J Allergy Clin Immunol 2012; 130:496-502.
18. Enjyoji K, Sevigny J, Lin Y et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 1999; 5:1010-7.
19. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-8.
20. Zhang G, Nie H, Yang J et al. Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol 2011; 301:L975-84.
21. Kwak YG, Song CH, Yi HK et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 2003; 111:1083-92.
22. Li P, Cao J, Chen Y et al. Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice. Int J Mol Med 2014; 34:269-75.
23. Levesque SA, Lavoie EG, Lecka J et al. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br J Pharmacol 2007; 152:141-50.
24. von Kugelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 2006; 110:415-32.
25. Burnstock G, Brouns I, Adriaensen D, Timmermans JP. Purinergic signaling in the airways. Pharmacol Rev 2012; 64:834-68.
26. Chavez J, Vargas MH, Rebollar-Ayala DC et al. Inhibition of extracellular nucleotides hydrolysis intensifies the allergic bronchospasm. A novel protective role of ectonucleotidases. Allergy 2013; 68:462-71.
27. Vieira RP, Muller T, Grimm M et al. Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammation. Am J Respir Crit Care Med 2011; 184:215-23.
28. Idzko M, C KA, Muller T et al. Attenuated allergic airway inflammation in Cd39 null mice. Allergy 2013; 68: 472-80.
29. Mascanfroni ID, Yeste A, Vieira SM et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat Immunol 2013; 14:1054-63.
30. Stummvoll GH, DiPaolo RJ, Huter EN et al. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J Immunol 2008; 181:1908-16.
31. Ye ZJ, Zhou Q, Du RH et al. Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion. Clin Vaccine Immunol 2011; 18:1608-15.
32. Grant CR, Liberal R, Holder BS et al. Dysfunctional CD39 regulatory T cells and aberrant control of T helper type 17 cells in autoimmune hepatitis. Hepatology 2014; 59:1007-15.
33. Younas M, Hue S, Lacabaratz C et al. IL-7 modulates in vitro and in vivo human memory T regulatory cell functions through the CD39/ATP axis. J Immunol 2013; 191:3161-8.
34. Nanzer AM, Chambers ES, Ryanna K et al. Enhanced production of IL-17A in patients with severe asthma is inhibited by 1alpha, 25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J Allergy Clin Immunol 2013; 132:297-304 e3.
35. Wang LL, Tang HP, Shi GC et al. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma. Mol Med Rep 2013; 8:1432-8.
36. Moncrieffe H, Nistala K, Kamhieh Y et al. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol 2010; 185:134-43.
37. Green RH, Brightling CE, Woltmann G et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57:875-9.
38. Swedin L, Neimert-Andersson T, Hjoberg J et al. Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice. Eur Respir J 2009; 34:200-8.